Approvals/TGA/PIPTAZ 4 g/0.5 g piperacillin (as piperacillin sodium) and tazobactam (as tazobactam sodium) 4 g / 500 mg powder for injection vial

Approved

STANDARD

PIPTAZ 4 g/0.5 g piperacillin (as piperacillin sodium) and tazobactam (as tazobactam sodium) 4 g / 500 mg powder for injection vial

Juno Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: df581fb8ce75a1f5
Product Name: PIPTAZ 4 g/0.5 g piperacillin (as piperacillin sodium) and tazobactam (as tazobactam sodium) 4 g / 500 mg powder for injection vial
Artg Id: 143494
Artg Name: PIPTAZ 4 g /0.5 g piperacillin (as sodium) and tazobactam (as sodium) 4 g / 500 mg powder for injection vial
Sponsor: Juno Pharmaceuticals Pty Ltd
Company Detail Path: /organization/juno-pharmaceuticals-pty-ltd
Artg Date: 2009-04-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-CMI-02762-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-PI-02764-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

df581fb8ce75a1f5

Type

Standard